Many neurological, autoimmune, and intracellular systemic challenges are complicated by the presence of biofilm infections. In these conditions, treatment is often more challenging as biofilm-generating pathogens can hide within the central nervous system, fatty tissues, or within the cells themselves. Biocidin®LSF uses liposomal technology to deliver Biocidin® straight into the bloodstream and the lymph for rapid systemic support. Lyme-literate practitioners appreciate liposomal delivery of Biocidin® for its enhanced intracellular uptake as demonstrated in our research.
Biocidin
$80.97
- Liposomal delivery for immediate systemic absorption and bioavailability from the oral cavity.
- Assists in the delivery of broad-spectrum botanicals to the central nervous system, a key benefit as nutritional support in Lyme disease or other microbial challenges outside the GI tract.
- Researched for intracellular absorption of ingredients.
- Enhances lymphatic circulation of therapeutic compounds.
- Unilamellar vesicles encapsulating Biocidin® have an optimal particle size of 100 nanometers.
- Research indicates potential in addressing biofilms and chronic/resistant cases of imbalanced terrain.
- Includes botanicals to assist detoxification pathways and to address inflammation.
Description
